|
Originally published In Press as doi:10.1074/jbc.M804846200 on September 10, 2008
J. Biol. Chem., Vol. 283, Issue 46, 32143-32151, November 14, 2008
Inactive and Active States of the Interferon-inducible Resistance GTPase, Irga6, in Vivo*
Natasa Papic ,
Julia P. Hunn ,
Nikolaus Pawlowski ,
Jens Zerrahn 1, and
Jonathan C. Howard 2
From the
Department of Cell Genetics, Institute for Genetics, University of Cologne, 50674 Cologne, Germany and the Department of Immunology, Max-Planck-Institute for Infection Biology, Schumannstrasse 21-22, 10117 Berlin, Germany
Irga6, a myristoylated, interferon-inducible member of the immunity-related GTPase family, contributes to disease resistance against Toxoplasma gondii in mice. Accumulation of Irga6 on the T. gondii parasitophorous vacuole membrane is associated with vesiculation and ultimately disruption of the vacuolar membrane in a process that requires an intact GTP-binding domain. The role of the GTP-binding domain of Irga6 in pathogen resistance is, however, unclear. We provide evidence that Irga6 in interferon-induced, uninfected cells is predominantly in a GDP-bound state that is maintained by other interferon-induced proteins. However, Irga6 that accumulates on the parasitophorous vacuole membrane after Toxoplasma infection is in the GTP-bound form. We demonstrate that a monoclonal antibody, 10D7, specifically detects GTP-bound Irga6, and we show that the formation of the 10D7 epitope follows from a GTP-dependent conformational transition of the N terminus of Irga6, anticipating an important role of the myristoyl group on Irga6 function in vivo.
Received for publication, June 25, 2008
, and in revised form, September 10, 2008.
* This study was supported by Deutsche Forschungsgemeinschaft Grants SPP1110, SFB635, and SFB670 and by the University of Cologne. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.
1 Present address: Institute of Clinical Pharmacology PAREXEL International GmbH, 14050 Berlin, Germany.
Author's Choice—Final version full access.
Author's Choice
Creative Commons Attribution Non-Commercial License applies to Author Choice Articles
2 To whom correspondence should be addressed: Institute for Genetics, University of Cologne, Zülpicher Str. 47, 50674 Cologne, Germany. Tel.: 49-2214704864; Fax: 49-2214706749; E-mail: j.howard{at}uni-koeln.de.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Zhao, D. J. P. Ferguson, D. C. Wilson, J. C. Howard, L. D. Sibley, and G. S. Yap
Virulent Toxoplasma gondii Evade Immunity-Related GTPase-Mediated Parasite Vacuole Disruption within Primed Macrophages
J. Immunol.,
March 15, 2009;
182(6):
3775 - 3781.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|